425 related articles for article (PubMed ID: 33761699)
1. Increased bleeding events with the addition of apixaban to the dual anti-platelet regimen for the treatment of patients with acute coronary syndrome: A meta-analysis.
Jin J; Zhuo X; Xiao M; Jiang Z; Chen L; Devi Shamloll Y
Medicine (Baltimore); 2021 Mar; 100(12):e25185. PubMed ID: 33761699
[TBL] [Abstract][Full Text] [Related]
2. Novel oral anticoagulants in acute coronary syndrome.
Costopoulos C; Niespialowska-Steuden M; Kukreja N; Gorog DA
Int J Cardiol; 2013 Sep; 167(6):2449-55. PubMed ID: 22989603
[TBL] [Abstract][Full Text] [Related]
3. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
Alexander JH; Wojdyla D; Vora AN; Thomas L; Granger CB; Goodman SG; Aronson R; Windecker S; Mehran R; Lopes RD
Circulation; 2020 May; 141(20):1618-1627. PubMed ID: 32223444
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.
Marquis-Gravel G; Neely ML; Valgimigli M; Costa F; Van Klaveren D; Altner R; Bhatt DL; Armstrong PW; Fox KAA; White HD; Ohman EM; Roe MT
Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006582. PubMed ID: 32862694
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort.
Obayashi Y; Watanabe H; Morimoto T; Yamamoto K; Natsuaki M; Domei T; Yamaji K; Suwa S; Isawa T; Watanabe H; Yoshida R; Sakamoto H; Akao M; Hata Y; Morishima I; Tokuyama H; Yagi M; Suzuki H; Wakabayashi K; Suematsu N; Inada T; Tamura T; Okayama H; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Morino Y; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
Circ Cardiovasc Interv; 2022 Aug; 15(8):e012004. PubMed ID: 35912647
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
[TBL] [Abstract][Full Text] [Related]
7. [Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation].
Darius H
Dtsch Med Wochenschr; 2020 Jul; 145(14):978-986. PubMed ID: 32668469
[TBL] [Abstract][Full Text] [Related]
8. Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial.
Sharma A; Hagström E; Wojdyla DM; Neely ML; Harrington RA; Wallentin L; Alexander JH; Goodman SG; Lopes RD;
Am Heart J; 2019 Sep; 215():106-113. PubMed ID: 31310855
[TBL] [Abstract][Full Text] [Related]
9. Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial.
Hess CN; James S; Lopes RD; Wojdyla DM; Neely ML; Liaw D; Hagstrom E; Bhatt DL; Husted S; Goodman SG; Lewis BS; Verheugt FWA; De Caterina R; Ogawa H; Wallentin L; Alexander JH
J Am Coll Cardiol; 2015 Aug; 66(7):777-787. PubMed ID: 26271059
[TBL] [Abstract][Full Text] [Related]
10. Apixaban with antiplatelet therapy after acute coronary syndrome.
Alexander JH; Lopes RD; James S; Kilaru R; He Y; Mohan P; Bhatt DL; Goodman S; Verheugt FW; Flather M; Huber K; Liaw D; Husted SE; Lopez-Sendon J; De Caterina R; Jansky P; Darius H; Vinereanu D; Cornel JH; Cools F; Atar D; Leiva-Pons JL; Keltai M; Ogawa H; Pais P; Parkhomenko A; Ruzyllo W; Diaz R; White H; Ruda M; Geraldes M; Lawrence J; Harrington RA; Wallentin L;
N Engl J Med; 2011 Aug; 365(8):699-708. PubMed ID: 21780946
[TBL] [Abstract][Full Text] [Related]
11. Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneous coronary intervention: A meta-analysis.
Wang Q; Yang K
Medicine (Baltimore); 2021 Apr; 100(15):e25546. PubMed ID: 33847681
[TBL] [Abstract][Full Text] [Related]
12. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials.
Liao YWB; Wang TKM
Coron Artery Dis; 2020 May; 31(3):260-265. PubMed ID: 31821195
[TBL] [Abstract][Full Text] [Related]
14. Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.
Cuisset T; Deharo P; Quilici J; Johnson TW; Deffarges S; Bassez C; Bonnet G; Fourcade L; Mouret JP; Lambert M; Verdier V; Morange PE; Alessi MC; Bonnet JL
Eur Heart J; 2017 Nov; 38(41):3070-3078. PubMed ID: 28510646
[TBL] [Abstract][Full Text] [Related]
15. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
; Alexander JH; Becker RC; Bhatt DL; Cools F; Crea F; Dellborg M; Fox KA; Goodman SG; Harrington RA; Huber K; Husted S; Lewis BS; Lopez-Sendon J; Mohan P; Montalescot G; Ruda M; Ruzyllo W; Verheugt F; Wallentin L
Circulation; 2009 Jun; 119(22):2877-85. PubMed ID: 19470889
[TBL] [Abstract][Full Text] [Related]
16. Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Hijazi Z; Alexander JH; Li Z; Wojdyla DM; Mehran R; Granger CB; Parkhomenko A; Bahit MC; Windecker S; Aronson R; Berwanger O; Halvorsen S; de Waha-Thiele S; Sinnaeve P; Darius H; Storey RF; Lopes RD
Circulation; 2021 Mar; 143(12):1215-1223. PubMed ID: 33461308
[TBL] [Abstract][Full Text] [Related]
17. Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.
Khan R; Lopes RD; Neely ML; Stevens SR; Harrington RA; Diaz R; Cools F; Jansky P; Montalescot G; Atar D; Lopez-Sendon J; Flather M; Liaw D; Wallentin L; Alexander JH; Goodman SG;
Heart; 2015 Sep; 101(18):1475-84. PubMed ID: 26109589
[TBL] [Abstract][Full Text] [Related]
18. Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis.
Zhuo X; Zhuo B; Ouyang S; Niu P; Xiao M
BMC Pharmacol Toxicol; 2018 Sep; 19(1):54. PubMed ID: 30176938
[TBL] [Abstract][Full Text] [Related]
19. Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis.
Bundhun PK; Huang F
BMC Cardiovasc Disord; 2018 May; 18(1):78. PubMed ID: 29720092
[TBL] [Abstract][Full Text] [Related]
20. Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?
Rubboli A; Oldgren J; Marìn F; Lip G
Intern Emerg Med; 2013 Dec; 8(8):673-80. PubMed ID: 24136072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
